1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 24 AUGUST 2015

Cancer Drug News 24 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Intensifying Early Access Climate Requires Companies To Be Proactive
Industry Brief - PharmaMar/STA Sign Aplidin Licensing Deal In Australia/New Zealand
Industry Brief - BioLineRx Initiates BL-8040 Phase IIb Trial In AML
Industry Brief - Adcetris Receives Regular FDA Approval For Classical HL Following HSCT
Industry Trend Analysis - Velcade Successor Will Face Tougher Market Environment
Industry Brief - Syndax Raises Funds To Support Entinostat Development
Industry Brief - MTG-201 Gains FDA ODD For Malignant Mesothelioma
Industry Brief - CHMP Issues Positive Opinion On Giotrif Label Update
Industry Brief - Telesta Therapeutics Closes USD28.6mn Private Placement
Industry Brief - Dosing Begins In MVI-816/Keytruda Combination Trial For PCA
Industry Brief - Spectrum/FDA Reach SPA Agreement On Apaziquone Phase III Trial In NMIBC
Industry Brief - Axalimogene Filolisbac/Durvalumab Combination Trial Begins In HPV-Associated Cancers
Industry Brief - FDA Grants Breakthrough Therapy Designation To Exelixis' Cabozantinib For Advanced RCC
Industry Brief - Dosing Begins In VBL's VB-111 Phase III Trial In rGBM
Industry Brief - Orbus Raises Funds To Advance Eflornithine In Recurrent Anaplastic Astrocytoma
Industry Trend Analysis - Limited Options Create Favourable Market Environment For Novartis' Odomzo
Industry Brief - FDA Grants Priority Review For Keytruda In First-Line Advanced Melanoma
Industry Brief - NMT Pharma/CAO Pharma Sign CZ-48 Worldwide Licensing Deal
Industry Brief - AstraZeneca/Peregrine Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - Liquid Biopsy/Genomic Data Combination Will Improve Drug Development
Industry Brief - R-Pharm Acquires Ixempra From BMS; Launches US Commercial Operations
Industry Brief - Cancer Conferences - October 2015

Table Of Contents

Cancer Drug News 24 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer and Breast Cancer Statistics in Switzerland

  • February 2017
    138 pages
  • Cancer  

    Breast Cancer  

    Obesity  

  • Switzerland  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics

5 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.